spacer
home > ict > our clients
OUR CLIENTS
<><><><><><><><><><><><><><><><><><><><><><><> 

Helvoet Pharma
helvoetpharma.com/en

Almac
http://www.almacgroup.com/
 
 
Bormioli Rocco
http://www.bormiolirocco.com/

Brecon Pharmaceuticals
http://www.brecon-pharm.co.uk/


BASF
http://www.corporate.basf.com/
Burkert
http://www.buerkert.com/

Cool Logistics
http://www.cool-logistics.com/

Domino Printing
www.domino-printing.com/uk

Fisher Scientific
http://www.fisher.co.uk/
IMA
http://www.ima.it/

Ingenia Technology
http://www.ingeniatechnology.com/
JDSU
http://www.jdsu.com/

Maxim Pharmaceuticals

Patheon
http://www.patheon.com/

QunetiQ
http://www.qinetiq.com/

Sun Chemical
http://www.sunchemical.com/

Sofrigam
http://www.sofrigam.com/

Weiler
http://www.weilercorp.com/

Ypsomed
http://www.ypsomed.com/
Soft Box Systems
http://www.softboxsystems.co.uk/

SigPack
sigpackinternationallive.screenlight.ch/eng/index.asp
Bosch
http://www.bosch.de/
Safechem
http://www.safechem.co.uk/
Rexam
http://www.rexam.com/

Pill Protect
http://www.pillprotect.com/

Aesica
http://www.aesica-pharma.co.uk/

Bag HealthCare
http://www.bag-healthcare.com/

Bang & Olufsen
http://www.bang-olufsen.com/

Solvay
http://www.solvay.com/

Sensitech
http://www.sensitech.com/
HPA
http://www.hpa.org.uk/

CurTec
http://www.curtec.com/

SMi
http://www.smi-online.co.uk/

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November
 
Industry Events

14th Annual Biomarkers & Immuno-Oncology World Congress

11-13 June 2018, Westin Boston Waterfront, Boston, Massachusetts

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 
News and Press Releases

POP TEST ADDRESSES THE PROBLEM OF UNRELIABLE DATA FROM CONTINUOUS GLUCOSE MONITORS

A major insight relating to the unreliability of data from continuous glucose monitors was published in the Nature journal, “Scientific Reports”, by Neil Theise, MD., the Lead Scientist of Pop Test, LLC and colleagues. The discovery of the “Interstitium”, a newfound human organ, by Dr. Theise and his collaborators, can be viewed by using the link https://www.nature.com/articles/s41598-018-23062-6 Continual glucose monitoring via an indwelling cutaneous needle measuring glucose in interstitial fluid (now identified to be in the “interstitium”) has been a game changer in the treatment of type 1 diabetes mellitus because of its accuracy. However, the needles used to collect this glucose containing fluid often fail in as little as a week. Despite the reliance on fluid from this space, the microanatomy of the interstitium has never been defined. The sensors currently in use were developed with the presumption of interstitial fluid being located somewhere in the sub-epidermal layers of the skin, but the actual anatomy relating to needle placement was always unclear.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement